Literature DB >> 1278188

[HGH secretion after oral application of L-dopa and L-carbidopa (author's transl)].

W Schönberger, R Ziegler, B Brodt, W Grimm.   

Abstract

The stimulatory effect of L-Dopa and L-Carbidopa (Nacom) on HGH secretion was determined in 12 children of normal height aged from 6 to 14 years. Each child received a standard dose of 250 mg L-Dopa and 25 mg L-Carbidopa p.o. HGH concentration in the serum was determined at standard intervals. All subjects showed a sufficient increase of HGH. The mean value was 19.6 ng/ml. According to the maximum values of the HGH concentration the sample can be divided into two groups; the first group reached the highest values after 20--40 min, the second one after 60--90 min. On evaluation of the curve of the mean values it appears that 2 blood samples taken 40 and 90 min after the ingestion of L-Dopa and L-Carbidopa are sufficient in order to exclude HGH deficiency. The theoretical background for HGH secretion after stimulation by L-Dopa and L-Carbidopa is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1278188     DOI: 10.1007/BF00463737

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  25 in total

1.  Growth hormone response to exercise. A test of pituitary function in children.

Authors:  B S Keenan; L B Killmer; J Sode
Journal:  Pediatrics       Date:  1972-11       Impact factor: 7.124

2.  Subcellular localization of neurotransmitters and releasing factors in the rat median eminence.

Authors:  F Clementi; B Ceccarelli; E Cerati; M L Demonte; M Felici; M Motta; A Pecile
Journal:  J Endocrinol       Date:  1970-10       Impact factor: 4.286

3.  Effect of various adrenergic receptor stimulating and blocking agents on human growth hormone secretion.

Authors:  F Massara; F Camanni
Journal:  J Endocrinol       Date:  1972-08       Impact factor: 4.286

4.  Norepinephrine and dopamine injection into lateral brain ventricle of the rat and growth hormone-releasing activity in the hypothalamus and plasma.

Authors:  E E Muller; A Pecile; M Felici; D Cocchi
Journal:  Endocrinology       Date:  1970-06       Impact factor: 4.736

5.  Apparent inadequency of L-dopa stimulation as a clinical test of growth hormone release.

Authors:  C Gómez-Sánchez; N M Kaplan
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

6.  Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonism.

Authors:  T N Chase; A M Watanabe
Journal:  Neurology       Date:  1972-04       Impact factor: 9.910

7.  Stimulation of human-growth-hormone secretion by L-dopa.

Authors:  A E Boyd; H E Lebovitz; J B Pfeiffer
Journal:  N Engl J Med       Date:  1970-12-24       Impact factor: 91.245

8.  Adrenergic control mechanism for vasopressin-induced plasma growth hormone response.

Authors:  S A Heidingsfelder; W G Blackard
Journal:  Metabolism       Date:  1968-11       Impact factor: 8.694

9.  Effects of autonomic blocking agents on growth hormone, insulin, free fatty acids and glucose in baboons.

Authors:  J H Werrbach; C C Gale; C J Goodner; M J Conway
Journal:  Endocrinology       Date:  1970-01       Impact factor: 4.736

10.  Human growth hormone secretion after exercise and oral glucose administration in patients with short stature.

Authors:  Y Okada; T Hikata; K Ishitobi; M Wada; Y Santo; Y Harada
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

View more
  2 in total

Review 1.  Growth hormone deficiency in children.

Authors:  Erick J Richmond; Alan D Rogol
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

2.  The effect of nacom (L-dopa and L-carbidopa) on growth hormone secretion in 75 patients with short stature.

Authors:  W Schönberger; W Grimm; R Ziegler
Journal:  Eur J Pediatr       Date:  1977-12-30       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.